"10.1371_journal.pone.0061297","plos one","2013-04-09T00:00:00Z","Gail V Matthews; Rachel J Ali; Anchalee Avihingsanon; Janaki Amin; Rachel Hammond; Scott Bowden; Sharon R Lewin; Joe Sasadeusz; Margaret Littlejohn; Stephen L Locarnini; Kiat Ruxrungtham; Gregory J Dore","Kirby Institute, University of New South Wales, Sydney, Australia; HIV-NAT, Thai Red Cross AIDS Research Centre, Department of Medicine, Chulongkorn University, Bangkok, Thailand; Victorian Infectious Diseases Reference Laboratory, Melbourne, Australia; Department of Medicine, Monash University, Melbourne, Australia; Infectious Diseases Unit, Alfred Hospital, Melbourne, Australia; Centre for Virology, Burnet Institute, Melbourne, Australia; The Royal Melbourne Hospital, Melbourne, Australia","Conceived and designed the experiments: GVM SRL SB SL GJD JS. Performed the experiments: RH SB ML. Analyzed the data: GVM RA JA AA GJD. Contributed reagents/materials/analysis tools: SB KR. Wrote the paper: GVM RA GJD.","The authors have read the journals policy and declare the following conflicts. Matthews GV: Grant funding: Gilead, MSD, Speakers bureau: Gilead, Roche, MSD, BMS, Janssen, Travel support: Janssen, MSD. Ali RJ: None. Avihingsanon A: None. Lewin SR: Grant funding: Gilead and Merck; Paid consultant and speaker: Gilead, Viiv Healthcare; Advisory Board: Gilead and Merck. Sasadeusz J: Gilead: research funding, meeting sponsorship, Merck: research funding, meeting sponsorship, BMS: research funding, Roche: research funding, paid speaker, advisory board. Hammond R: None. Bowden S: Speaker with honorarium for Gilead, Bristol-Myers Squibb, Roche and Merck. Littlejohn M: None. Locarnini S: Royalties â€ â€œ Melbourne Health; Receipt of Intellectual Property Rights/Patent Holder â€ â€œ Melbourne Health; Consulting Fees (eg. Advisory Boards) â€ Evivar Pty Ltd, Gilead, Bristol-Myers Squibb; Fees for Non-CME Services Received Directly from a Commercial Interest or their Agent - Bristol-Myers Squibb, Merck Sharpe and Dohme Pty Ltd. Ruxrungtham K has been awarded Senior Researcher Scholar, Thai Research Fund; The National Research University Project of CHE (HR1161A), Ministry of Education; and the Professional Research Team Strengthening Fund, from the National Science and Technology Development Agency (NSTDA),BIOTEC, Ministry of Science and Technology; Thailand. He has also served as a consultant for Merck, and Tibotec. He has been a speaker with honorarium for Bristol-Myers Squibb, Merck, Roche, Jensen-Cilag, GlaxoSmithKline, and GPO. Dore GJ: Board membership: Roche, Merck, Janssen, Gilead, BMS; Honoraria: Roche, Merck, Janssen, Gilead, BMS; Research grants: Roche, Merck, Janssen, Gilead, BMS; Scholarship: Roche, Merck, Janssen. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","04","Gail V Matthews","GVM",12,TRUE,6,3,5,3,TRUE,TRUE,FALSE,0,NA,FALSE
